What is Microtrace?
Microtrace operates as a premier materials analysis laboratory, distinguished by its specialization in the characterization and identification of minute quantities and single particles of unknown substances. Leveraging advanced microscopy and microchemical techniques, the company provides critical analytical support for a diverse clientele. This includes services for criminal and civil litigation, as well as essential support for industries such as insurance, pharmaceuticals, food, environmental, and manufacturing. Microtrace's expertise is also applied to forensic art analysis, contaminant identification, and the resolution of consumer complaints. With an international reputation built over three decades, Microtrace is recognized for its unwavering commitment to quality and its rigorous scientific methodology in addressing complex analytical challenges.
How much funding has Microtrace raised?
Microtrace has raised a total of $348K across 2 funding rounds:
Debt
$150K
Debt
$198K
Debt (2020): $150K with participation from PPP
Debt (2021): $198K led by PPP
Key Investors in Microtrace
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Microtrace?
The substantial capital infusion, particularly the recent strategic investment, positions Microtrace for accelerated expansion and enhanced service offerings. This significant backing suggests a focus on scaling operations, potentially through the adoption of new technologies or the expansion of its analytical capabilities. The company is likely to further solidify its international standing and deepen its market penetration across various industrial and legal sectors. Future developments may include strategic partnerships or acquisitions aimed at broadening its service portfolio and reinforcing its leadership in advanced materials analysis.
See full Microtrace company page
